🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib trial studies the best dose, safety, and effect of alisertib ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2020-06-18
Trial ID
NCT04479306
Treatments Being Tested
This phase II trial is studying the side effects of and how well alisertib ...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2011-02
Trial ID
NCT01154816
Treatments Being Tested
This is a single-arm, open-label, multicenter, dose escalation, phase 1-2 s...
Status
Completed
Location
Multiple Locations
Start Date
2011-08-09
Trial ID
NCT01397825
Treatments Being Tested
The purpose of this study is to assess the mass balance (i.e. cumulative ex...
Status
Completed
Location
Comprehensive Clinical Development
Start Date
2013-01-24
Trial ID
NCT01714947
Treatments Being Tested
This is an open-label, multicenter, phase 1 study of MLN8237 in participant...
Status
Completed
Location
Multiple Locations
Start Date
2008-07-11
Trial ID
NCT00697346
Treatments Being Tested
To determine the dose-limiting toxicity (DLT) and maximum tolerated dose (M...
Status
Completed
Location
Sarah Cannon Research Institute (SCRI)
Start Date
2007-05-15
Trial ID
NCT00500903
Treatments Being Tested
This is an open label phase I trial designed to evaluate the maximum tolera...
Status
Withdrawn
Location
Houston Methodist Cancer Center
Start Date
2015-12
Trial ID
NCT02780011
Treatments Being Tested
This phase I trial studies the side effects and the best dose of MLN8237 (a...
Status
Completed
Location
Washington University School of Medicine
Start Date
2013-05-07
Trial ID
NCT01677559
Treatments Being Tested
The purpose of this study is to evaluate the effect of food on the single-d...
Status
Completed
Location
Multiple Locations
Start Date
2013-07-16
Trial ID
NCT01898078
Treatments Being Tested
This phase II trial studies how well alisertib with or without fulvestrant ...
Status
Completed
Location
Georgetown University Medical Center
Start Date
2017-07-06
Trial ID
NCT02860000
Treatments Being Tested